Simple health tools for better health outcomes

About Us

AceAge Inc. is a healthcare technology company, creating intuitive products to ease the aging process and improve health outcomes.

Our upcoming product Karie is a personal health companion that organizes, schedules, and dispenses pills with one-button technology, ensuring that patients are taking the right medication at the right time. Karie is easy to use, enables greater patient autonomy and ensures better healthcare through a highly coordinated program.

In addition to the release of Karie in 2018, AceAge has been working on various other upcoming initiatives, including i2P2 Studies and Applied Facial Recognition.

Our Team

Spencer Waugh

CEO

Spencer is the well-rounded leader and CEO of AceAge, the innovative company behind the healthcare tech product Karie. His background lies in pharma, healthcare technology, and investment industries.
In 2016, he was awarded with SmartStart from Ontario Centres of Excellence and with Fuel Injection from Innovation Guelph. Waugh has spoken at a number of Healthcare-Tech conferences including Healthkick, Aging 2.0, MedEdge and Apps4Health.

Pascal
Tyrrell

CSO

Pascal is a data scientist—a combination of research methodologist, computer/database solutions architect and innovator. He received his PhD in medical sciences from the University of Toronto working in the area of pediatric rheumatology at SickKids (Toronto, ON).
Currently, he is the director of data science and an assistant professor with the Department of Medical Imaging, University of Toronto where his aim is to understand, explore, and innovate where information and communications technology can be used effectively to encourage the translation of health research into action. Pascal is also appointed to the Department of Statistical Sciences where his research aims to establish useful guidelines for the quantity and quality of input data for machine learning in medical imaging research by investigating current methods as well as developing new ones. Pascal has previous work experience in the computer and financial industries and more recently, he has joined the medical device tech start-up company AceAge Inc. as their Chief Scientific Officer.

Sam Campbell

CTO

Prior to taking on the role as AceAge’s Chief Technology Officer, Sam was the Senior Software Engineer for PerkinElmer, Inc., a global leader in biotechnology.
Sam was responsible for ensuring the safety and security of patient data in clinical research at PerkinElmer. Sam received his Masters of Computer Science at the University of Waterloo, his Bachelor of Science from the University of Guelph, and was given the Computer Engineering Award upon completing his diploma at Seneca.

Wes
van Ooyen

CPO

A hands-on hardware team lead with proven success developing and delivering innovative high tech pharmacy products while developing teams and processes from start-up through commercialization and beyond.

Board of Directors

Spencer Waugh CEO AceAge Inc.

Spencer is the well-rounded leader and CEO of AceAge, the innovative company behind the healthcare tech product Karie. His background lies in pharma, healthcare technology, and investment industries. In 2016, he was awarded with SmartStart from Ontario Centres of Excellence and with Fuel Injection from Innovation Guelph. Waugh has spoken at a number of Healthcare-Tech conferences including Healthkick, Aging 2.0, MedEdge and Apps4Health.

Don Waugh CEO Applied Recognition

Don has over 15 years of extensive experience in the high tech sector most recently as the Founder and Co-CEO of Applied Recognition. Previously he was the CEO and Founder of PCAS Patient Care Automation Services which is revolutionizing the dispensing and management of prescription medicine.

Prior to PCAS Don was the founder Echoworx Corporation, an encryption security software company specializing in Internet based applications. Previously to that he was the founder of CoolWater/CIMtegration, an internet development firm and DataVation, a data storage company. Professionally Don was a CMA becoming an entrepreneur nearly 20 years ago. He is a multi-patent holder for encryption technologies, drug dispensing systems and face recognition applications.

David Murphy CEO Centric Health

Mr. Murphy brings over 12 years of healthcare experience to Centric Health. He joins the Company from Cardinal Health, where he has served as President of its $1.2 billion Canadian business since 2016.  During this time, he led a strategic transformation of the Canadian organization, which included integration of the Patient Recovery business purchased from Medtronic.

Previously, Mr. Murphy was President of the Canadian division of Stryker from 2008 to 2016.  Under his leadership, the organization strengthened its market leadership position, improved operating margins and earned consistent recognition as a top Canadian employer and workplace.  Mr. Murphy holds MBA and LL.B. degrees from the University of Toronto.

Martin Gurbin President Metamor Health Inc.

Martin (Marty) works with hospital leaders, clinicians, scientists, academics, entrepreneurs and multinationals, business accelerators and governments, in Canada and internationally, to identify and translate new ideas within health systems that simultaneously improve quality and efficiency of care and generate economic returns.

Over the past 2 decades, Marty has been engaged in a wide range of initiatives and strategies related to health system innovation, healthcare technology development, commercialization and adoption, development of multi-stakeholder domestic and international partnerships and entrepreneurship development. He has served as Sr. Economist at the Ontario Hospital Association, Director of the Council of Academic Hospitals of Ontario, the Director of Business Development and Innovation at Sunnybrook Health Sciences Centre, Founder and Vice President of Sunnybrook International, and currently provides strategic insight and guidance to >100 emerging and established healthcare technology and lifesciences companies/year as Innovation Broker within Ontario’s Office of Chief Health Innovation Strategist and through his own company Metamor Health Inc.

Kym Anthony Interim CEO Avivagen

Mr. G. F. Anthony is Chairman, President & Chief Executive Officer at Avivagen, Inc., Executive Chairman at Hybrid Partners Ltd., Executive Chairman at Top Meadow Investments, Chairman at Access Energy Technologies Ltd., Chief Executive Officer at Dundee Insurance Agency Ltd., Executive Chairman at Broadacre Agriculture, Inc., a Member at Mount Royal Club and a Member at Toronto Stock Exchange, Inc.

He is on the Board of Directors at Canadian Opera Co. and COM DEV International Ltd. Mr. Anthony was previously employed as Deputy Chairman by Mackie Research Capital Asset Management, Deputy Chairman by Mackie Research Capital Corp., President & Chief Executive Officer by National Bank Financial, Inc., President & Chief Executive Officer by National Bank Financial, Inc. (Broker), Chairman by ProMetic Life Sciences, Inc., President & Chief Executive Officer by First Marathon, Inc., President & Chief Executive Officer by National Bank of Canada, Vice Chairman by TD Waterhouse Bank, NA, Vice Chairman by The Toronto-Dominion Bank, Treasurer & Risk Manager by CIBC World Markets, Head-Fixed Income & Derivatives by Commercial International Brokerage Co., Executive Chairman by Dundee Bank of Canada, President & Chief Executive Officer by Dundee Mortgage Services, Inc., President, Chief Executive Officer & Director by DWM Securities, Inc., Chairman by exactEarth Ltd., Deputy Chairman by DundeeWealth, Inc., Chairman by Investment Dealers Association of Canada, Chairman by Nabco Systems LLC, Vice Chairman by TD Bank NA, and Chairman & Chief Executive Officer by TD Securities, Inc.

He also served on the board at PCAS Patient Care Automation Services, Inc., Favored, Inc. and Peel Career Assessment Services, Inc.

He received his undergraduate degree from Simon Fraser University and an MBA from the University of Western Ontario.

Karie

Organizes. Schedules. Reminds. Delivers. Monitors.

Karie is a home health appliance that organizes and delivers medication. It’s a personal healthcare companion, empowering users and improving health outcomes.

Karie provides an automated solution to the common, costly, but completely preventable problem of poor medication adherence for elderly patients living alone.

Why Karie?

%

Enables People to Age in Place

23% of patients in long term care are institutionalized because they cannot take their medication properly. AARP reports that 90% of seniors wish to age in their own homes. Karie allows aging individuals to age in place by automating medication regimens.

Relieves Caregivers

Karie reduces the burden on caregivers by eliminating the stress of medication non-adherence. In addition to Karie’s scheduling and delivery features, the device uses smartphone technology to alert family when a patient has missed a dosage.

Security Features

  • Face Recognition
  • Pin Code
  • Early Dose Prevention
    • Bolt to Countertop
    • Lock in Cartridge
    • Disable Early Dispense Function
  • Cartridge Mismatch Notification
  • 72 Hours Battery Backup

Reduces Healthcare Costs

Karie can mitigate the cost of medication non-adherence, which is $290 billion in the US annually. Karie removes the chance of non-adherence through human error via its ability to organize, deliver and monitor medication regimens leading to better health outcomes and increasing one’s control over their care.

Video

Learn how Karie works.

Are you leaving the house for an extended period of time? Karie’s Going Out feature enables users to dispense the medication you will need while absent. Watch how it works.

Karie has a single-load action and dispenses pills with one-button control. This easy to use appliance uses pouch-packaging that is administered by your pharmacist. Watch how to load Karie.

Karie reminds users to take their medication by lighting up and making a chiming noise. Watch how Karie reminds.

Press Releases

Media

Research

%

A study conducted with University of Toronto demonstrated that the medication delivery device increases medication adherence by 300%.
i

University of Toronto Study

This pilot was a randomized, cross-over study in which the participants underwent three weeks of medication treatment with the assistance of Karie and three weeks of medication treatment without using Karie.
University of Toronto students were recruited as participants and took Omega-3 dietary supplements. Medication adherence was measured by a device delivery log, pill count and as 7 day recall. The 12 participants also completed an exit survey and interview. Only 20% of participants were considered to have been adherent during the control phase, in comparison to 80% were considered to have been adherent using Karie. The study demonstrated that Karie, the medication delivery device, increases medication adherence by 300%.
i

Upcoming i2p2 Study

This study will utilize a multi-site randomized controlled trial design to investigate the efficacy of the KARIE Automated Medication Delivery Device in enhancing medication adherence among a group of community-dwelling patients immediately following discharge from inpatient rehabilitation.
Participants will be recruited from West Park Healthcare Centre in Toronto (n=150) and CapitalCare in Edmonton (n=150) where consenting patients will be randomly assigned to receive medication self-management education only (SME) or medication self-management education + KARIE (AceAge Inc.) (SME+K).Outcome measures include: medication adherence, usability and feasibility.

Collaborators

Amazing Organizations We’re Working With

Sign up to be notified about Karie’s release